Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$116.5K
10.50K shares
What this filing means
CARTER TODD ALFRED plans to sell 10.50K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $116.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2023ACC: 0001959173-23-002273
Officer· Chief Scientific Officer
Since Feb 2026
10.50K
Shares to sell
$116.5K
Approx. market value
5.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months5
Restricted Stock Vesting
Compensation
2/10/2022
845.00Restricted Stock Vesting
Compensation
1/11/2022
1.07KRestricted Stock Vesting
Compensation
2/10/2021
1.44KRestricted Stock Vesting
Compensation
1/11/2021
1.08KRestricted Stock Vesting
Compensation
1/11/2020
1.07KTotal acquired5.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2022 | Restricted Stock Vesting Compensation | 845.00 | — |
1/11/2022 | Restricted Stock Vesting Compensation | 1.07K | — |
2/10/2021 | Restricted Stock Vesting Compensation | 1.44K | — |
1/11/2021 | Restricted Stock Vesting Compensation | 1.08K | — |
1/11/2020 | Restricted Stock Vesting Compensation | 1.07K | — |
| Total | 5.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5K
Market value
$57.0K
6/30/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.50K
Market value
$59.4K
7/6/2023
Total
Units
10.50K
Value
$116.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2023 | 5K | $57.0K | — | Completed |
| Planned — Approximate Date | ||||
7/6/2023 | 5.50K | $59.4K | NASDAQ | Planned |
| Total | 10.50K | $116.5K | ||